News Daily News Nonstatin Use and Expenditures Are Up Despite the Dearth of Evidence Supporting Efficacy Yael L. Maxwell January 29, 2018
News Daily News Maze of Prior Authorization for PCSK9 Inhibitors Poses Challenge to Prescribers Yael L. Maxwell January 24, 2018
News Daily News Synopsis of New Hypertension Guidelines Renews Concerns and Controversy L.A. McKeown January 22, 2018
News Daily News High Rate of Clinical Events at 6 Months for Ischemic CVD Patients Michael O'Riordan January 19, 2018
News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Daily News Some Concerns About New ‘Tour de Force’ Hypertension Guidelines Todd Neale December 04, 2017
News Daily News ACC Provides Guidance on How to Manage Bleeding in Patients Taking Oral Anticoagulants Todd Neale December 04, 2017
News Conference News AHA 2017 CANTOS: Big Drop in CVD Events Among Canakinumab Responders Michael O'Riordan November 13, 2017
News Daily News As Hypertension Sweeps China, Awareness, Treatment, and Control Remain Poor Todd Neale October 26, 2017
News Daily News ‘J-Curve’ in Hypertension May Be Explained by Differences in Patient Characteristics Todd Neale September 26, 2017
News Daily News Ischemic Heart Disease the Leading Cause of Death Globally Michael O'Riordan September 19, 2017
News Conference News ESC 2017 ESC Releases Revamped DAPT Guidance Focusing on Personalized Approach Todd Neale September 01, 2017
News Daily News Popular CV Risk Calculator Is Not Accurate Among Patients at Low Socioeconomic Standing Yael L. Maxwell August 31, 2017
News Conference News ESC 2017 IMPACT-AF: Education, Feedback Boost Oral Anticoagulation Use for A-fib Todd Neale August 30, 2017
News Conference News ESC 2017 Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab Michael O'Riordan August 28, 2017
News Opinion Editor's Corner ESC 2017 ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On Shelley Wood August 18, 2017
News Daily News Money-Back Guarantee for Evolocumab Has Little Impact on Cost-Effectiveness Michael O'Riordan August 08, 2017
News Daily News ADAPT-DES at 2 Years Offers Insights Into Provider Strategies and Aspirin Monotherapy Beyond 1 Year Yael L. Maxwell August 07, 2017
News Daily News Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete? Michael O'Riordan June 05, 2017